Form 4 holding
SVP, DEV & HEAD OF IRE OFFICE
Theravance Biopharma, Inc.
- Security class
- Ordinary Shares
- Shares / value
- 189,826
- Estimated value
- $3,227,042
- Report date
- 20 Aug 2026
- Price
- $17.00
- Ownership
- Direct
Aine Miller - SVP, DEV & HEAD OF IRE OFFICE at Theravance Biopharma, Inc.
Issuer-level insider activity
- Role
- Svp, Dev & Head Of Ire Office
- Issuer ticker
- TBPH on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Aine Miller since 04 Sep 2025
Reported holdings for Aine Miller in Theravance Biopharma, Inc.
Transaction history for Aine Miller in Theravance Biopharma, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.